Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Esteban, Rafael"" wg kryterium: Autor


Tytuł :
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management.
Autorzy :
Grau-López L; Addiction and Dual Diagnosis Section, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Marcos-Fosch C; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Daigre C; Addiction and Dual Diagnosis Section, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Palma-Alvarez RF; Addiction and Dual Diagnosis Section, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Rando-Segura A; Liver Disease-Viral Hepatitis Laboratory, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Llaneras J; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Perea-Ortueta M; Addiction and Dual Diagnosis Section, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Rodriguez-Frias F; Liver Disease-Viral Hepatitis Laboratory, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Martínez-Luna N; Addiction and Dual Diagnosis Section, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Ramos-Quiroga JA; Addiction and Dual Diagnosis Section, Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Colom J; Director of the Programme for Prevention, Control and Treatment of HIV, STIs and Viral Hepatitis. Agency of Public Health of Catalonia. Generalitat de Catalunya.
Esteban R; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Buti M; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Passeig Vall Hebron 119-129, Barcelona, 08035, Spain.
Pokaż więcej
Źródło :
Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2021 Aug 27; Vol. 14, pp. 17562848211016563. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease.
Autorzy :
Palom, Adriana (AUTHOR)
Sopena, Sara (AUTHOR)
Riveiro‐Barciela, Mar (AUTHOR)
Carvalho‐Gomes, Angela (AUTHOR)
Madejón, Antonio (AUTHOR)
Rodriguez‐Tajes, Sergio (AUTHOR)
Roade, Luisa (AUTHOR)
García‐Eliz, María (AUTHOR)
García‐Samaniego, Javier (AUTHOR)
Lens, Sabela (AUTHOR)
Berenguer‐Hayme, Marina (AUTHOR)
Rodríguez‐Frías, Francisco (AUTHOR)
Hernandez‐Évole, Helena (AUTHOR)
Isabel Gil‐García, Ana (AUTHOR)
Barreira, Ana (AUTHOR)
Esteban, Rafael (AUTHOR)
Buti, Maria (AUTHOR)
Pokaż więcej
Źródło :
Alimentary Pharmacology & Therapeutics. Aug2021, Vol. 54 Issue 4, p462-469. 8p. 2 Charts, 3 Graphs.
Czasopismo naukowe
Tytuł :
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study.
Autorzy :
Riveiro-Barciela M; Department of Medicine of the UAB, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Marcos-Fosch C; Department of Medicine of the UAB, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Martinez-Valle F; Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Bronte F; Sezione di Gastroenterologia, Di.Bi.M.I.S, University of Palermo, Palermo 90133, Italy.
Orozco O; Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Sanz-Pérez I; Systemic Autoimmune Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Torres D; Sezione di Gastroenterologia, Di.Bi.M.I.S, University of Palermo, Palermo 90133, Italy.
Salcedo MT; Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Petta S; Sezione di Gastroenterologia, Di.Bi.M.I.S, University of Palermo, Palermo 90133, Italy.
Esteban R; Department of Medicine of the UAB, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Craxi A; Sezione di Gastroenterologia, Di.Bi.M.I.S, University of Palermo, Palermo 90133, Italy.
Buti M; Department of Medicine of the UAB, Hospital Universitari Vall d'Hebron, Barcelona 08035, Spain.
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Aug 14; Vol. 27 (30), pp. 5112-5125.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Etiologies and Features of Acute Viral Hepatitis in Spain.
Autorzy :
Llaneras J; Emergency Room Department, Vall d'Hebron University Hospital, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Barcelona, Spain.
Rando-Segura A; Biochemistry and Microbiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Marcos-Fosch C; Emergency Room Department, Vall d'Hebron University Hospital, Barcelona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Roade L; Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Barcelona, Spain.
Velázquez F; Biochemistry and Microbiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Rodríguez-Frías F; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Barcelona, Spain; Biochemistry and Microbiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Esteban R; Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Barcelona, Spain.
Buti M; Liver Unit, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Barcelona, Spain. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 May; Vol. 19 (5), pp. 1030-1037. Date of Electronic Publication: 2020 Jul 11.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis A*/complications
Hepatitis A*/epidemiology
Hepatitis C*
Hepatitis E*/complications
Hepatitis E*/epidemiology
Adult ; Female ; Hepacivirus ; Humans ; Male ; Spain/epidemiology
Czasopismo naukowe
Tytuł :
Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B.
Autorzy :
Papatheodoridis GV; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Laiko', Athens, Greece.
Dalekos GN; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
Idilman R; Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
Sypsa V; Department of Hygiene, Epidemiology & Medical Statistics, Medical School of National and Kapodistrian University of Athens, Athens, Greece.
Van Boemmel F; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
Buti M; Hospital General Universitario Vall Hebron and Ciberehd, Barcelona, Spain.
Calleja JL; Hospital U Puerta de Hierro, IDIPHIM CIBERehd, Madrid, Spain.
Goulis J; 4th Department of Internal Medicine, Αristotle University of Thessaloniki Medical School, Thessaloniki, Greece.
Manolakopoulos S; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Laiko', Athens, Greece.; 2nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Hippokratio', Athens, Greece.
Loglio A; Division of Gastroenterology and Hepatology, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Papatheodoridi M; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Laiko', Athens, Greece.
Gatselis N; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
Veelken R; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
Lopez-Gomez M; Hospital U Puerta de Hierro, IDIPHIM CIBERehd, Madrid, Spain.
Hansen BE; Department of Gastroenterology & Hepatology, Erasmus MC University Medical Center, Rotterdam, Netherlands.; Liver Clinic, Toronto Western & General Hospital, University Health Network, Toronto, ON, Canada.
Savvidou S; 4th Department of Internal Medicine, Αristotle University of Thessaloniki Medical School, Thessaloniki, Greece.
Kourikou A; 2nd Department of Internal Medicine, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Hippokratio', Athens, Greece.
Vlachogiannakos J; Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens 'Laiko', Athens, Greece.
Galanis K; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.
Yurdaydin C; Department of Gastroenterology & Hepatology, Koc University Medical School, Istanbul, Turkey.
Esteban R; Hospital General Universitario Vall Hebron and Ciberehd, Barcelona, Spain.
Janssen HLA; Liver Clinic, Toronto Western & General Hospital, University Health Network, Toronto, ON, Canada.
Berg T; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
Lampertico P; Division of Gastroenterology and Hepatology, CRC 'A. M. and A. Migliavacca' Center for Liver Disease, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Pokaż więcej
Źródło :
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Apr 20; Vol. 3 (3), pp. 100290. Date of Electronic Publication: 2021 Apr 20 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.
Autorzy :
Buti M; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Stepanova M; Center for Outcomes Research in Liver Disease, Washington, DC, USA.
Palom A; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.
Riveiro-Barciela M; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Nader F; Center for Outcomes Research in Liver Disease, Washington, DC, USA.
Roade L; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Esteban R; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Younossi Z; Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA.; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Pokaż więcej
Źródło :
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Mar 17; Vol. 3 (3), pp. 100280. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis.
Autorzy :
Martínez-Campreciós J; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Rando-Segura A; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Buti M; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; CIBERehd, Instituto Carlos II, Spain. Electronic address: .
Rodrigo-Velásquez F; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; CIBERehd, Instituto Carlos II, Spain.
Barreira-Díaz A; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain.
Álvarez-López P; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain.
Salmerón P; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Palom A; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain.
Tabernero D; CIBERehd, Instituto Carlos II, Spain; Liver Pathology Unit, Biochemistry and Microbiology Departments, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Palomo N; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain.
Nindia A; Hospital Nossa Senhora da Paz, Cubal, Angola.
Barbosa G; Hospital Nossa Senhora da Paz, Cubal, Angola.
López E; Hospital Nossa Senhora da Paz, Cubal, Angola.
Ferreira V; Hospital General de Benguela, Universidade Katyavla Bwila, Benguela, Angola.
Saiago N; Hospital General de Benguela, Universidade Katyavla Bwila, Benguela, Angola.
Kuchta A; Roche Molecular Systems, Inc. Pleasanton, CA, USA.
Ferrer-Costa R; Biochemistry Department, Clinical Laboratories Hospital Universitari Vall d'Hebron, Spain.
Esteban R; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 080335 Barcelona, Spain; CIBERehd, Instituto Carlos II, Spain.
Molina I; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.
Rodríguez-Frías F; CIBERehd, Instituto Carlos II, Spain; Biochemistry Department, Clinical Laboratories Hospital Universitari Vall d'Hebron, Spain; Liver Pathology Unit, Biochemistry and Microbiology Departments, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Pokaż więcej
Źródło :
Journal of virological methods [J Virol Methods] 2021 Mar; Vol. 289, pp. 114039. Date of Electronic Publication: 2020 Dec 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B.
Autorzy :
Roade L; Liver Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebrón, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Madrid, Spain.
Riveiro-Barciela M; Liver Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebrón, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Madrid, Spain.
Esteban R; Liver Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebrón, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Madrid, Spain.
Buti M; Liver Unit, Internal Medicine Department, Hospital Universitario Vall d'Hebrón, Vall d'Hebron Barcelona Hospital Campus, Barcelona, 119-129, Spain. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Carlos III, Madrid, Spain.
Pokaż więcej
Źródło :
Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2021 Feb 05; Vol. 8, pp. 2049936120985954. Date of Electronic Publication: 2021 Feb 05 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
The Screening Guidelines for Hepatitis C Virus Infection as a milestone in the path towards hepatitis C virus elimination.
Autorzy :
Calleja Panero JL; Aparato Digestivo, Hospital Universitario Puerta de Hierro, España.
Esteban R; Hepatología, Hospital Universitario Vall d'Hebron, España.
Pokaż więcej
Źródło :
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva [Rev Esp Enferm Dig] 2021 Feb; Vol. 113 (2), pp. 156.
Typ publikacji :
Journal Article
MeSH Terms :
Hepacivirus*
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Hepatitis C*/prevention & control
Humans ; Mass Screening
Czasopismo naukowe
Tytuł :
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response.
Autorzy :
Younossi ZM; Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia; Inova Medicine, Inova Health System, Falls Church, Virginia; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia. Electronic address: .
Racila A; Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia; Inova Medicine, Inova Health System, Falls Church, Virginia.
Muir A; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Bourliere M; Department of Hepato- Gastroenterology, Hospital Saint Joseph, Marseille, France.
Mangia A; IRCCS Casa Sollievo della Sofferenza Hospital, Liver Unit, Medical Sciences, San Giovanni Rotondo, Italy.
Esteban R; Liver Unit, Hospital Universitari Vall d'Hebron and Ciberehd del Instituto Carlos III, Barcelona, Spain.
Zeuzem S; Department of Medicine I at the Goethe University Hospital, Frankfurt, Germany.
Colombo M; Liver Center for Translational Research, IRCCS Humanitas, Milan, Italy.
Manns M; Hannover Medical School, Hannover, Germany.
Papatheodoridis GV; Academic Gastroenterology Department, Laiko Hospital, Athens, Greece.
Buti M; Liver Unit, Hospital Universitari Vall d'Hebron and Ciberehd del Instituto Carlos III, Barcelona, Spain.
Chokkalingam A; Gilead Sciences, Foster City, California.
Gaggar A; Gilead Sciences, Foster City, California.
Nader F; Center for Outcomes Research in Liver Disease, Washington, District of Columbia.
Younossi I; Center for Outcomes Research in Liver Disease, Washington, District of Columbia.
Henry L; Center for Outcomes Research in Liver Disease, Washington, District of Columbia.
Stepanova M; Center for Outcomes Research in Liver Disease, Washington, District of Columbia.
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Jan 22. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies